Logo image of NMS

NUVEEN MN QLTY MUNI INC (NMS) Stock Price, Quote, News and Overview

NYSE:NMS - New York Stock Exchange, Inc. - US6707341029 - Currency: USD

11.73  +0.04 (+0.34%)

Fundamental Rating

1

NMS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. Both the profitability and financial health of NMS have multiple concerns. NMS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year NMS has reported negative net income.
In the past year NMS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: NMS reported negative net income in multiple years.
Each year in the past 5 years NMS had a positive operating cash flow.
NMS Yearly Net Income VS EBIT VS OCF VS FCFNMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M

1.2 Ratios

Industry RankSector Rank
ROA -2.49%
ROE -4.19%
ROIC 0.5%
ROA(3y)-0.83%
ROA(5y)0.58%
ROE(3y)-1.63%
ROE(5y)0.76%
ROIC(3y)1.36%
ROIC(5y)1.52%
NMS Yearly ROA, ROE, ROICNMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5

1.3 Margins

NMS's Operating Margin has declined in the last couple of years.
In the last couple of years the Gross Margin of NMS has declined.
Industry RankSector Rank
OM 23.35%
PM (TTM) N/A
GM 25.15%
OM growth 3Y-26.62%
OM growth 5Y-18.9%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-25.03%
GM growth 5Y-18.45%
NMS Yearly Profit, Operating, Gross MarginsNMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 200

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for NMS remains at a similar level compared to 1 year ago.
Compared to 5 years ago, NMS has about the same amount of shares outstanding.
The debt/assets ratio for NMS is higher compared to a year ago.
NMS Yearly Shares OutstandingNMS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
NMS Yearly Total Debt VS Total AssetsNMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M

2.2 Solvency

NMS has an Altman-Z score of 0.80. This is a bad value and indicates that NMS is not financially healthy and even has some risk of bankruptcy.
NMS has a debt to FCF ratio of 12.24. This is a negative value and a sign of low solvency as NMS would need 12.24 years to pay back of all of its debts.
A Debt/Equity ratio of 0.68 indicates that NMS is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 12.24
Altman-Z 0.8
ROIC/WACCN/A
WACCN/A
NMS Yearly LT Debt VS Equity VS FCFNMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 5.67 indicates that NMS has no problem at all paying its short term obligations.
NMS has a Quick Ratio of 5.67. This indicates that NMS is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 5.67
Quick Ratio 5.67
NMS Yearly Current Assets VS Current LiabilitesNMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M

More info and screens

0

3. Growth

3.1 Past

NMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 60.45%, which is quite impressive.
Looking at the last year, NMS shows a very negative growth in Revenue. The Revenue has decreased by -16.71% in the last year.
Measured over the past years, NMS shows a very negative growth in Revenue. The Revenue has been decreasing by -11.09% on average per year.
EPS 1Y (TTM)60.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%112.5%
Revenue 1Y (TTM)-16.71%
Revenue growth 3Y-13.77%
Revenue growth 5Y-11.09%
Sales Q2Q%64.71%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NMS Yearly Revenue VS EstimatesNMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NMS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NMS Price Earnings VS Forward Price EarningsNMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 16.98
EV/EBITDA N/A
NMS Per share dataNMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.90%, NMS is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.45, NMS pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.9%

5.2 History

The dividend of NMS decreases each year by -7.05%.
NMS has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of NMS decreased recently.
Dividend Growth(5Y)-7.05%
Div Incr Years1
Div Non Decr Years1
NMS Yearly Dividends per shareNMS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

NMS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-98.04%
EPS Next 2YN/A
EPS Next 3YN/A
NMS Yearly Income VS Free CF VS DividendNMS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M

More info and screens

NUVEEN MN QLTY MUNI INC

NYSE:NMS (4/30/2025, 8:25:01 PM)

11.73

+0.04 (+0.34%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners8.29%
Inst Owner Change14.51%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap69.09M
Analysts0
Price TargetN/A
Short Float %0.23%
Short Ratio0.9
Dividend
Industry RankSector Rank
Dividend Yield 6.9%
Yearly Dividend0.52
Dividend Growth(5Y)-7.05%
DP-98.04%
Div Incr Years1
Div Non Decr Years1
Ex-Date04-15 2025-04-15 (0.0735)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 20.69
P/FCF 16.98
P/OCF 16.98
P/B 0.95
P/tB 0.95
EV/EBITDA N/A
EPS(TTM)-0.53
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.69
FCFY5.89%
OCF(TTM)0.69
OCFY5.89%
SpS0.57
BVpS12.39
TBVpS12.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.49%
ROE -4.19%
ROCE 0.64%
ROIC 0.5%
ROICexc 0.5%
ROICexgc 0.5%
OM 23.35%
PM (TTM) N/A
GM 25.15%
FCFM 121.86%
ROA(3y)-0.83%
ROA(5y)0.58%
ROE(3y)-1.63%
ROE(5y)0.76%
ROIC(3y)1.36%
ROIC(5y)1.52%
ROICexc(3y)1.37%
ROICexc(5y)1.53%
ROICexgc(3y)1.37%
ROICexgc(5y)1.53%
ROCE(3y)1.73%
ROCE(5y)1.93%
ROICexcg growth 3Y-34.24%
ROICexcg growth 5Y-26.22%
ROICexc growth 3Y-34.24%
ROICexc growth 5Y-26.22%
OM growth 3Y-26.62%
OM growth 5Y-18.9%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-25.03%
GM growth 5Y-18.45%
F-Score5
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 12.24
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 0.48
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.67
Quick Ratio 5.67
Altman-Z 0.8
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%112.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-16.71%
Revenue growth 3Y-13.77%
Revenue growth 5Y-11.09%
Sales Q2Q%64.71%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-68.42%
EBIT growth 3Y-36.73%
EBIT growth 5Y-27.89%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-25.59%
FCF growth 3Y2.4%
FCF growth 5Y15.15%
OCF growth 1Y-25.59%
OCF growth 3Y2.4%
OCF growth 5Y15.15%